1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Catheter Precision, Inc.

Catheter Precision, Inc.

VTAK
Catheter Precision, Inc.US flagNew York Stock Exchange Arca
0.21
USD
+0.01
- -
565,419.00Market Cap

Total Valuation

Catheter Precision, Inc. carries a market capitalization of 565,419.00, placing it among publicly traded companies globally. Its enterprise value stands at 14.46M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap565,419.00
Enterprise Value14.46M

Share Statistics

Catheter Precision, Inc. currently has 3.61M shares outstanding.

Shares Outstanding3.61M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.93, and the price-to-book ratio stands at 0.17.

PE RatioN/A
PS Ratio0.93
PB Ratio0.17
P/TBV Ratio-0.22
P/FCF Ratio-0.19
P/OCF Ratio-0.19

Enterprise Valuation

EV / Sales7.55
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Catheter Precision, Inc. maintains a current ratio of 0.19, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 79.68, indicating elevated leverage, while an interest coverage ratio of -20.42 demonstrates limited ability to service its debt obligations.

Current Ratio0.19
Quick Ratio0.15
Debt / Equity79.68
Debt / EBITDA-1.37
Interest Coverage-20.42

Financial Efficiency

Return on Equity (ROE)-103.95
Return on Assets (ROA)-40.54
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover14.72

Taxes

Income Tax-623,000.00
Effective Tax RateN/A

Stock Price Statistics

Catheter Precision, Inc.'s stock has declined approximately -91.53226% over the past 52 weeks. The 50-day moving average sits at 0.43, while the 200-day moving average is 1.22.

Beta (5Y)N/A
52-Week Price Change-91.53226%
50-Day Moving Average0.43
200-Day Moving Average1.22
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Catheter Precision, Inc. generated 1.92M in revenue and converted that into -12.66M in net income, yielding earnings per share of -6.30. EBITDA reached -9.97M, while operating income came in at -12.16M.

Revenue1.92M
Gross Profit914,000.00
Operating Income-12.16M
Pretax Income-13.81M
Net Income-12.66M
EBITDA-9.97M
EBIT-12.16M
Earnings Per Share (EPS)-6.30

Balance Sheet

Catheter Precision, Inc. holds 1.84M in cash and equivalents against 13.66M in total debt, resulting in a net debt position of 10.38M. Total book value stands at 17.56M, with working capital of -10.94M providing operational flexibility.

Cash & Cash Equivalents1.84M
Total Debt13.66M
Net Debt10.38M
Equity (Book Value)17.56M
Book Value Per Share4.87
Working Capital-10.94M

Cash Flow

Catheter Precision, Inc. produced -9.35M in operating cash flow over the past twelve months. After subtracting -234,000.00 in capital expenditures, free cash flow totaled -9.59M - equivalent to -4.58 per share.

Operating Cash Flow-9.35M
Capital Expenditures-234,000.00
Free Cash Flow-9.59M
FCF Per Share-4.58

Margins

Catheter Precision, Inc. operates with a gross margin of 47.73, reflecting its pricing power and cost economics. The operating margin of -634.99 and net profit margin of -660.89 provide insight into operational efficiency.

Gross Margin47.73
Operating Margin-634.99
Pretax Margin-721.20
Profit Margin-660.89
EBITDA Margin-520.47

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-362.84
FCF Yield-513.06

Stock Splits

Catheter Precision, Inc.'s most recent stock split took place on August 15, 2025 with a 19:1 split ratio.

Last Split Date8/15/2025
Split Ratio19:1

Scores

Catheter Precision, Inc. posts an Altman Z-Score of -92.55, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-92.55